User profiles for Holly Hagan

Holly Hagan

Professor, College of Global Public Health, New York University
Verified email at nyu.edu
Cited by 66504

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

…, D Gunnell, R Gupta, J Haagsma, H Hagan… - The lancet, 2012 - thelancet.com
Background Measuring disease and injury burden in populations requires a composite metric
that captures both premature mortality and the prevalence and severity of ill-health. The …

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

…, D Gunnell, R Gupta, J Haagsma, H Hagan… - The lancet, 2012 - thelancet.com
Background Non-fatal health outcomes from diseases and injuries are a crucial consideration
in the promotion and monitoring of individual and population health. The Global Burden of …

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

…, R Gosselin, B Grant, HR Gutierrez, H Hagan… - Jama, 2013 - jamanetwork.com
Importance Understanding the major health problems in the United States and how they are
changing over time is critical for informing national health policy. Objectives To measure the …

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

PK Nelson, BM Mathers, B Cowie, H Hagan… - The Lancet, 2011 - thelancet.com
Background Injecting drug use is an important risk factor for transmission of viral hepatitis, but
detailed, transparent estimates of the scale of the issue do not exist. We estimated national…

Sharing of drug preparation equipment as a risk factor for hepatitis C.

H Hagan, H Thiede, NS Weiss… - American journal of …, 2001 - ncbi.nlm.nih.gov
OBJECTIVES: This study investigated the sharing of drug preparation equipment as a
possible route of hepatitis C virus (HCV) transmission. METHODS: HCV seroconversion was …

Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial

…, CF Turner, H Miller, J Gribble, Q Shi, H Hagan… - The Lancet, 1999 - thelancet.com
Background We aimed to assess audio-computer-assisted self-interviewing (audio-CASI)
as a method of reducing under-reporting of HIV risk behaviour among injecting drug users. …

A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs

H Hagan, ER Pouget… - Journal of Infectious …, 2011 - academic.oup.com
Introduction. High rates of hepatitis C virus (HCV) transmission are found in samples of
people who inject drugs (PWID) throughout the world. The objective of this paper was to meta-…

[PDF][PDF] Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta‐analysis

…, CG Beckwith, ND Zaller, DD Jarlais, H Hagan… - …, 2013 - Wiley Online Library
People detained in prisons and other closed settings are at elevated risk of infection with
hepatitis C virus (HCV). We undertook a systematic review and meta‐analysis with the aim of …

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

…, J Reed, P Vickerman, H Hagan… - Cochrane Database …, 2017 - cochranelibrary.com
Holly Hagan … Previous reviews have failed to define the frequency of use of the
intervention and/or the coverage of the intervention (defined as the quantity of needles/syringes …

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review …

L Platt, S Minozzi, J Reed, P Vickerman, H Hagan… - …, 2018 - Wiley Online Library
Aims To estimate the effects of needle and syringe programmes (NSP) and opioid substitution
therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV…